| 000 | 01168 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511193816.0 | ||
| 264 | 0 | _c19920713 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a0740-7378 | ||
| 024 | 7 |
_a10.1016/b978-0-7506-9265-6.50012-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClements, M L | |
| 245 | 0 | 0 |
_aInfluenza vaccines. _h[electronic resource] |
| 260 |
_bBiotechnology (Reading, Mass.) _c1992 |
||
| 300 |
_a129-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDNA, Recombinant _xtherapeutic use |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInfluenza Vaccines _ximmunology |
| 650 | 0 | 4 |
_aOrthomyxoviridae _ximmunology |
| 650 | 0 | 4 |
_aPoxviridae _xgenetics |
| 650 | 0 | 4 |
_aVaccines, Attenuated _ximmunology |
| 650 | 0 | 4 |
_aVaccines, Inactivated _ximmunology |
| 773 | 0 |
_tBiotechnology (Reading, Mass.) _gvol. 20 _gp. 129-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/b978-0-7506-9265-6.50012-9 _zAvailable from publisher's website |
| 999 |
_c1606852 _d1606852 |
||